1. Spiro-beta-Lactam BSS-730A Displays Potent Activity against HIV and Plasmodium. Bártolo, I., B.S. Santos, D. Fontinha, M. Machado, D. Francisco, B. Sepodes, J. Rocha, H. Mota-Filipe, R. Pinto, M.E. Figueira, H. Barroso, T. Nascimento, A.P. Alves de Matos, A.J.S. Alves, N.G. Alves, C.J.V. Simões, M. Prudêncio, E.M.T. Pinho, and N. Taveira. ACS Infectious Diseases, 2021. 7(2): p. 421-434. PMID[33395253].
[PubMed]. HIV_02_2021.
2. Design, Synthesis, and Evaluation of "Dual-site"-Binding Diarylpyrimidines Targeting Both NNIBP and the NNRTI Adjacent Site of the HIV-1 Reverse Transcriptase. Feng, D., X. Zuo, L. Jing, C.H. Chen, F.A. Olotu, H. Lin, M. Soliman, E. De Clercq, C. Pannecouque, K.H. Lee, D. Kang, X. Liu, and P. Zhan. European Journal of Medicinal Chemistry, 2021. 211: 113063. PMID[33340914].
[PubMed]. HIV_02_2021.
3. Natural Cystatin C Fragments Inhibit GPR15-mediated HIV and SIV Infection without Interfering with GPR15L Signaling.Hayn, M., A. Blotz, A. Rodriguez, S. Vidal, N. Preising, L. Standker, S. Wiese, C.M. Sturzel, M. Harms, R. Gross, C. Jung, M. Kiene, T. Jacob, S. Pohlmann, W.G. Forssmann, J. Munch, K.M.J. Sparrer, K. Seuwen, B.H. Hahn, and F. Kirchhoff. Proceedings of the National Academy of Sciences of the United States of America, 2021. 118(3): e2023776118. PMID[33431697]. PMCID[PMC7826402].
[PubMed]. HIV_02_2021.
4. Hybrids of Small-molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors. Kobayakawa, T., K. Tsuji, K. Konno, A. Himeno, A. Masuda, T. Yang, K. Takahashi, Y. Ishida, N. Ohashi, T. Kuwata, K. Matsumoto, K. Yoshimura, H. Sakawaki, T. Miura, S. Harada, S. Matsushita, and H. Tamamura. Journal of Medicinal Chemistry, 2021. 64(3): p. 1481-1496. PMID[33497209].
[PubMed]. HIV_02_2021.
5. Small-molecule anti-HIV-1 Agents Based on HIV-1 Capsid Proteins. Kobayakawa, T., M. Yokoyama, K. Tsuji, M. Fujino, M. Kurakami, S. Boku, M. Nakayama, M. Kaneko, N. Ohashi, O. Kotani, T. Murakami, H. Sato, and H. Tamamura. Biomolecules, 2021. 11(2): 208. PMID[33546092]. PMCID[PMC7913237].
[PubMed]. HIV_02_2021.
6. A Novel Selective Histone Deacetylase I Inhibitor CC-4a Activates Latent HIV-1 through NF-kB Pathway. Lu, W., C. Yang, X. Xu, C. Chen, X. Hou, H. Fang, and S. Liu. Life Sciences, 2021. 267: 118427. PMID[32941894].
[PubMed]. HIV_02_2021.
7. Syntheses and anti-HIV and Human Cluster of Differentiation 4 (CD4) Down-modulating Potencies of Pyridine-fused Cyclotriazadisulfonamide (CADA) Compounds. Lumangtad, L.A., E. Claeys, S. Hamal, A. Intasiri, C. Basrai, E. Yen-Pon, D. Beenfeldt, K. Vermeire, and T.W. Bell. Bioorganic & Medicinal Chemistry, 2020. 28(24): 115816. PMCID[33181479]. PMCID[PMC7741178].
[PubMed]. HIV_02_2021.
8. In Vitro Study on Synergistic Interactions between Free and Encapsulated Q-Griffithsin and Antiretrovirals against HIV-1 Infection. Minooei, F., J.R. Fried, J.L. Fuqua, K.E. Palmer, and J.M. Steinbach-Rankins. International Journal of Nanomedicine, 2021. 16: p. 1189-1206. PMID[33623382]. PMCID[PMC7894819].
[PubMed]. HIV_02_2021.
9. Boesenmaxane Diterpenoids from Boesenbergia maxwellii. Moe, T.S., S. Chaturonrutsamee, S. Bunteang, C. Kuhakarn, S. Prabpai, P. Surawatanawong, A. Chairoungdua, K. Suksen, R. Akkarawongsapat, J. Limthongkul, C. Napaswad, N. Nuntasaen, and V. Reutrakul. Journal of Natural Products, 2021. 84(2): p. 518-526. PMID[33372792].
[PubMed]. HIV_02_2021.
10. Synthesis and Biological Evaluation of Pyrrolidine-functionalized Nucleoside Analogs. Seneviratne, U., S. Wickramaratne, D. Kotandeniya, A.S. Groehler, R.J. Geraghty, C. Dreis, S.S. Pujari, and N.Y. Tretyakova. Medicinal Chemistry Research, 2021. 30: p. 483-499. ISI[000614335700003].
[WOS]. HIV_02_2021.
11. Discovery of Novel HIV-1 Integrase-LEDGF/p75 Allosteric Inhibitors Based on a Pyridine Scaffold Forming an Intramolecular Hydrogen Bond. Sugiyama, S., T. Akiyama, Y. Taoda, T. Iwaki, E. Matsuoka, E. Akihisa, T. Seki, T. Yoshinaga, and T. Kawasuji. Bioorganic & Medicinal Chemistry Letters, 2021. 33: 127742. PMID[33316407].
[PubMed]. HIV_02_2021.
12. γ-Non-symmetrically Dimasked TriPPPro Prodrugs as Potential Antiviral Agents against HIV. Zhao, C., X. Jia, D. Schols, J. Balzarini, and C. Meier. ChemMedChem, 2021. 16(3): p. 499-512. PMID[33089929]. PMCID[PMC7894357].
[PubMed]. HIV_02_2021.
Patent Citations
13. Hepatitis B Virus-derived Polypeptide and Anti-viral Use Thereof. Kim, B.J., Y.M. Choi, and H. Kim. Patent. 2021. 2020-17090485 20210054029: 48pp , Cont -in-part of Appl No PCT/KR2019/005302.
[Patent]. HIV_02_2021.
14. Preparation of 4'-Ethynyl-2'-deoxyadenosine Derivs. And Their Use in HIV Therapy. Miller, J., V. Samano, D. Temelkoff, and E.J. Velthuisen. Patent. 2021. 2020-IB57221 2021024114: 62pp.
[Patent]. HIV_02_2021.
15. Patentiflorin a Analogs as Antiviral Agents. Zhang, H., W. Li, and N.Y. Tsang. Patent. 2021. 2020-16947935 20210060042: 146pp.
[Patent]. HIV_02_2021.